Osimertinib vs Vipivotide Tetraxetan Lutetium

## Osimertinib vs Vipivotide Tetraxetan Lutetium: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Vipivotide Tetraxetan Lutetium**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Vipivotide Tetraxetan Lutetium — N/A.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Vipivotide Tetraxetan Lutetium — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Vipivotide Tetraxetan Lutetium — N/A.

**Type**: Osimertinib — Small molecule; Vipivotide Tetraxetan Lutetium — Protein.